Wang et al. combined PD-1 with TRBC1 for the diagnosis and monitoring of AITL, including minimal residual disease (MRD), and showed high sensitivity and specificity [14]. This evidence concerns the gene PDCD1 and angioimmunoblastic T-cell lymphoma.